Tacoma, Wash.-based MultiCare Health System is taking a step forward in improving its revenue cycle processes by piloting a new generative AI solution from Xsolis.
Category: Featured
MultiCare becomes 1st health system to pilot new AI tool
Tacoma, Wash.-based MultiCare Health System is taking a step forward in improving its revenue cycle processes by piloting a new generative AI solution from Xsolis.
Montefiore's financial comeback: From $28.6M operating loss to $147M gain
New York City-based Montefiore Health System reported $147.4 million in operating income (2.3% margin) for the nine months ending Sept. 30, a significant turnaround from the $28.6 million loss (-0.5% margin) reported during the same period last year.&n…
Top 10 states by IT workforce
As health systems aim to boost their digital footprints, some states may provide a better opportunity to land IT professionals.
CVS makes new leadership appointments
CVS Health has announced two key leadership appointments as part of its ongoing efforts to enhance pharmacy and wellness services.
The CommonSpirit region that 'remains challenged'
California was CommonSpirit’s top-performing market in terms of margins in the first quarter of fiscal year 2025 (the three months ending Sept. 30) but the Chicago-based system’s South region, which includes Texas and Kentucky, “remains challenged,” Be…
RWJBarnabus names chief pediatric surgeon
New Brunswick, N.J.-based RWJBarnabas Health named pediatric surgeon Steven Stylianos, MD, as system director for pediatric surgery and surgeon-in-chief at the Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital.
Duke Regional names interim president
Jason Carter has been named interim president and COO of Duke Regional Hospital in Durham, N.C., according to a Dec. 2 post on his LinkedIn page.
What's going on with prior authorization?
Here are three recent updates on prior authorization for ASC physicians and leaders to know:
GLP-1s and heart outcomes: 5 recent findings
With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound can address outcomes in cardiovascular health…
